Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The PI3K/Akt signaling pathway is an intracellular cascade that regulates key cellular processes such as growth, proliferation, survival, metabolism, and apoptosis. It is frequently dysregulated in diseases like cancer and diabetes. Activation involves growth factors binding to receptor tyrosine kinases (RTKs) or G protein-coupled receptors (GPCRs), leading to PI3K activation, PIP3 production, Akt recruitment/activation, and downstream effects on various cellular functions. The pathway is negatively regulated by PTEN and protein phosphatases. Therapeutic targeting is an area of intense research.
Inhibition of PI3K, Akt, or downstream targets to reduce signaling.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoinositide 3-kinase-Protein Kinase B Signaling Pathway (PI3K/Akt pathway).